Important Information

Announcement by the Management Board of the Frankfurt Stock Exchange according to Sec.50a para.3 of the German Stock Exchange Ac

On 30 April 2025 the Management Board of  the  Frankfurt  Stock  Exchange  revoked the  admission  to  the  sub-segment  of  the regulated market with additional obligations (Prime Standard) of the shares of Medigene  AG,  Planegg/Martinsriedex officio  according  to  Sec.57  Abs.2  BörsO FWB, Sec.42 para.2 of the German Stock Exchange   Act.   For   further   information regarding trading please see the publication on xetra.com.

The decision   is not  yet final  and conclusive.

Date: 30 April 2025